Latest Breaking News On - நச்சு விளைவுகள் - Page 1 : comparemela.com

Pfizer-BioNTech’s COVID-19 vaccine effective and safe for use among cancer patients Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer. “To our knowledge, this study is the first to prospectively characterize the serologic status, immunogenicity, and safety of the BNT162b2 vaccine in a cohort of patients with solid tumors who are receiving active anticancer therapies,” writes the team from the Rambam Health Care Campus, the Rappaport Faculty of Medicine, and the Technion-Integrated Cancer Center, in Haifa. While the efficacy and safety profiles of COVID-19 vaccines have previously been demonstrated in phase 3 studies, the team says patients with cancer were not adequately represented in these trials.

Irit ben aharonSally robertsonRambam health care campusCancer centerRappaport facultyTechnion integrated cancer centerSerologic statusToxic effectsPatients undergoing treatmentImage creditசாலி ராபர்ட்சன்புற்றுநோய் மையம்ராப்பபோர்ட் ஆசிரியதொழில்நுட்பம் ஒருங்கிணைந்த புற்றுநோய் மையம்நச்சு விளைவுகள்படம் கடன்